278 related articles for article (PubMed ID: 2947818)
41. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
Kumari GI; Das RP; Madoiya KK; Jain AK; Roy S
Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
[TBL] [Abstract][Full Text] [Related]
42. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
[TBL] [Abstract][Full Text] [Related]
43. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
[TBL] [Abstract][Full Text] [Related]
44. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
[TBL] [Abstract][Full Text] [Related]
45. Novel peptides in ovarian follicular fluid: implications for contraceptive development.
Schwartz NB
Res Front Fertil Regul; 1982 Sep; 2(2):1-11. PubMed ID: 12179632
[TBL] [Abstract][Full Text] [Related]
46. Dual suppression with oral contraceptives and gonadotrophin releasing-hormone agonists improves in-vitro fertilization outcome in high responder patients.
Damario MA; Barmat L; Liu HC; Davis OK; Rosenwaks Z
Hum Reprod; 1997 Nov; 12(11):2359-65. PubMed ID: 9436663
[TBL] [Abstract][Full Text] [Related]
47. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
[TBL] [Abstract][Full Text] [Related]
48. Current status of antagonistic analogs of LH-RH as a contraceptive method in the female.
Schally AV
Res Front Fertil Regul; 1983 Jul; 2(5):1-16. PubMed ID: 12179624
[TBL] [Abstract][Full Text] [Related]
49. Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, and ovarian follicle development in heifers continuously infused with a gonadotropin-releasing hormone agonist.
Gong JG; Campbell BK; Bramley TA; Gutierrez CG; Peters AR; Webb R
Biol Reprod; 1996 Jul; 55(1):68-74. PubMed ID: 8793060
[TBL] [Abstract][Full Text] [Related]
50. The effects of estrogen and progesterone on the functional capacity of the gonadotrophs.
Lasley BL; Wang CF; Yen SS
J Clin Endocrinol Metab; 1975 Nov; 41(5):820-6. PubMed ID: 1102551
[TBL] [Abstract][Full Text] [Related]
51. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
[TBL] [Abstract][Full Text] [Related]
52. GnRH analogues for contraception.
Fraser HM
Br Med Bull; 1993 Jan; 49(1):62-72. PubMed ID: 8324616
[TBL] [Abstract][Full Text] [Related]
53. [Contraception with cyclic administration of buserelin and gestagens: increase in testosterone and free testosterone serum concentration].
Pietzsch V; Kuhl H
Geburtshilfe Frauenheilkd; 1991 Oct; 51(10):819-23. PubMed ID: 1837002
[TBL] [Abstract][Full Text] [Related]
54. [Ultrasonic and hormonal monitoring of the ovaries during mini-dose oral contraception].
Doyen J; Schaaps JP; Lambotte R
Contracept Fertil Sex (Paris); 1987 May; 15(5):529-33. PubMed ID: 12268693
[TBL] [Abstract][Full Text] [Related]
55. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
Nillius SJ; Bergquist C; Wide L
Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
[TBL] [Abstract][Full Text] [Related]
56. Pituitary and ovarian response to acute stimulation with LH-RH in normal and anovulatory women.
Aparicio NJ; Casas PR; Galimberti DM; de Laborde NP; Badano A; García EP; Meichi HR; Mirkin A; Szejner M; Jaitt A; Margulies M; Rosner JM
Int J Fertil; 1977; 22(1):6-15. PubMed ID: 18416
[TBL] [Abstract][Full Text] [Related]
57. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
58. Timing of onset of contraceptive effectiveness in Depo-Provera users. II. Effects on ovarian function.
Petta CA; Faúndes A; Dunson TR; Ramos M; DeLucio M; Faúndes D; Bahamondes L
Fertil Steril; 1998 Nov; 70(5):817-20. PubMed ID: 9806559
[TBL] [Abstract][Full Text] [Related]
59. Gonadotroph and corpus luteum responses to two successive intranasal doses of a luteinizing hormone-releasing hormone agonist at different days after the midcycle luteinizing hormone surge.
Lemay A; Faure N; Labrie F; Fazekas AT
Fertil Steril; 1983 May; 39(5):661-7. PubMed ID: 6404660
[TBL] [Abstract][Full Text] [Related]
60. Ovarian morphology and pituitary gonadotrophins in serum during and after long-term treatment with oral contraceptives.
Starup J; Visfeldt J
Acta Obstet Gynecol Scand; 1974; 53(2):161-7. PubMed ID: 4822347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]